Divis Labs Chippada facility gets zero USFDA observations Medical Dialogues Bureau4 Feb 2020 9:45 AM IST "This is to inform you that the Company's Unit-II at Village Chippada, Bheemunipatnam District, Andhra Pradesh has had an inspection by the US Food...
Eugia Pharma gets USFDA nod for generic drug: Aurobindo Pharma MD bureau1 Feb 2020 10:15 AM ISTNew Delhi: Aurobindo Pharma on Friday said its joint venture firm Eugia Pharma Specialities has received approval from the US health regulator to...
USFDA cautions Aurobindo Pharma's oral solids formulation facility of regulatory action MD bureau31 Jan 2020 1:29 PM ISTNEW DELHI: Drug firm Aurobindo Pharma on Thursday reported that the US health regulator has cautioned that its oral solids formulation manufacturing...
Aurobindo Pharma gets official action indicated classification from USFDA for its plant Meghna A Singhania30 Jan 2020 4:14 PM ISTNew Delhi: Aurobindo Pharma has announced that the US Food and Drug Administration (FDA) classified the inspection of the company's oral solids...
Alembic Pharmaceuticals gets USFDA Approval for Azithromycin Tablets Medical Dialogues Bureau29 Jan 2020 1:25 PM ISTAlembic Pharmaceuticals announces USFDA Final Approval for Azithromycin Tablets USP, 600 mg. Alembic Pharmaceuticals Limited (Alembic) has announced...
Cipla gets USFDA EIR for Invagen manufacturing facility Medical Dialogues Bureau29 Jan 2020 12:57 PM ISTNew Delhi: Homegrown pharma major Cipla on Tuesday said it has received a report from the US health regulator indicating closure of the inspection at...
USFDA issues Form 483 with 5 observations to Biocon Bengaluru facility MD bureau28 Jan 2020 2:24 PM ISTNew Delhi: Biocon Ltd on Monday said the US health regulator conducted a pre-approval inspection and good manufacturing practice (GMP) examination of...
USFDA completes inspection of Strides Pharma's Alathur facility with zero observations MD bureau26 Jan 2020 2:00 PM ISTNew Delhi: Drug firm Strides Pharma Science on Friday said the US health regulator has completed inspection of its Alathur facility in Tamil Nadu with...
Alembic Pharma gets final USFDA nod for Bosentan tablets to treat pulmonary arterial hypertension Medical Dialogues Bureau25 Jan 2020 12:11 PM ISTNew Delhi: Alembic Pharmaceuticals (Alembic) on Friday said it has received final nod from US health regulator for Bosentan tablets, used for...
FDA warns about potential cybersecurity vulnerabilities for certain GE Healthcare Clinical Information Central Stations and Telemetry Servers Medical Dialogues Bureau24 Jan 2020 10:50 AM ISTUS: U.S. Food and Drug Administration is issuing a safety communication informing health care providers, facilities and patients about cybersecurity...
Cipla gets USFDA observations for its Goa facility Medical Dialogues Bureau23 Jan 2020 3:23 PM ISTNew Delhi: Drug firm Cipla on Wednesday said it has received observations from the USFDA for its Goa manufacturing facility. It further said that the...
Piramal Group to infuse Rs 500 crore in pharma operations in Telangana Medical Dialogues Bureau23 Jan 2020 10:15 AM ISTHyderabad: Healthcare major Piramal Group has agreed to invest Rs 500 crore over the next three years in Telangana for setting up new facilities and...
